By: Theresa Yarbrough
Founder/Director at the Georgia Cannabis Industry Alliance – a fair trade organization
Tuesday July 21, 2026

Georgia has no remediation disclosure requirements — and no published remediation standards. This single fact shapes the entire medical marijuana program, and it’s one of the most misunderstood parts of Georgia’s MMJ system.

Why Georgia hides remediation, failed tests, and safety data from patients

Georgia hides this information for four core reasons — all baked into the design of the Haleigh’s Hope Act and the GMCC regulatory framework.

1. To protect the operators, not the patients

Georgia’s MMJ program is a restricted‑license monopoly:

• 6 operators

• 1 testing lab

• no competition

• no public COA system

• no transparency requirements

If Georgia published:

• failed tests

• contamination results

• remediation logs

• batch histories

• pre‑remediation COAs

…it would expose how often products fail and how often they are remediated. That would damage operator reputation and threaten the political stability of the program.

So the state hides it.

2. To avoid political embarrassment

Georgia’s MMJ program is tiny, fragile, and politically sensitive.

If the public saw:

• how many batches fail

• how often mold or pesticides appear

• how often potency is corrected

• how often terpenes are stripped and re‑infused

• how often remediation is used

…it would undermine the state’s claim that the program is “safe,” “regulated,” and “high quality.”

Transparency would reveal the truth: Georgia’s system is barely functioning.

So the state hides it.

3. To avoid lawsuits and liability

If patients could see:

• failed COAs

• contamination histories

• remediation treatments

• chemical corrections

• irradiation logs

they could sue:

• operators

• the lab

• the state

• the Commission

• the Department of Public Health

Georgia’s secrecy clause (O.C.G.A. § 16‑12‑223) exists specifically to prevent this. It shields operators, applicants, testing labs, and regulators from public scrutiny and legal exposure.

So the state hides it.

4. To maintain control over the narrative

Georgia’s cannabis program is built on political control, not patient access.

If patients had access to real data, they could:

• demand better standards

• demand independent labs

• demand transparency

• demand adult‑use

• demand homegrow

• demand accountability

The state does not want an informed cannabis public.

So the state hides it.

The real reason (the one I’ve been pointing out):

If Georgia published remediation and failed tests, the entire medical program would collapse under its own data.

The secrecy clause exists because transparency would expose:

• contamination

• remediation

• potency manipulation

• terpene manipulation

• batch failures

• operator shortcuts

• lab limitations

• regulatory weakness

Georgia’s MMJ program is held together by opacity, not science.

Georgia’s single testing lab makes secrecy possible — and makes a second lab essential

Georgia’s remediation secrecy is only possible because the state relies on one state‑approved testing lab. With no independent labs, no competition, and no alternative verification, operators face no pressure to disclose failures or remediation.

A monopoly testing system means:

• the operator controls the sample

• the lab controls the data

• the state only sees what the operator chooses to submit

• patients have no second opinion

• failed tests never reach the public

• remediation logs never reach regulators

• batch histories never reach patients

This is the structural reason transparency collapses.

A second independent lab would break this cycle immediately. Competition forces accuracy. Independent verification forces honesty. Multiple labs force transparency.

Georgia’s entire secrecy model depends on having only one lab. The moment there are two, the system changes.

How remediation works in Georgia

1. Georgia DOES allow remediation

Georgia’s rules permit operators to “correct” failed batches using post‑processing techniques, including:

• microbial reduction

• irradiation

• chemical treatments

• solvent‑based microbial correction

• terpene stripping

• potency correction

• re‑infusion

• cosmetic restoration

These are standard remediation methods in limited‑license states. Georgia does not prohibit any of them.

2. Georgia does NOT require operators to disclose remediation

This is the core problem.

Georgia’s MMJ regulations do not require disclosure of:

• failed tests

• what failed

• remediation methods

• chemicals used

• irradiation

• terpene stripping

• potency correction

• re‑infusion

• batch history

• pre‑remediation COAs

Patients only see the final COA, which is the post‑remediation result.

The original failed COA is hidden. The remediation process is hidden. The batch history is hidden.

This is why Georgia’s system is considered one of the least transparent in the country.

3. Georgia does NOT require labs to report remediation to the state

Labs like SJ Labs:

• test the product

• send results to the operator

• do not automatically send results to GMCC

• do not send failed COAs to GMCC

• do not send remediation notes to GMCC

GMCC only sees results if they request them during an audit.

This allows operators to remediate quietly.

4. Georgia does NOT require operators to destroy failed batches

Unlike states with strict consumer protection laws (CO, MI, MA), Georgia:

• allows remediation

• does not require destruction

• does not require public reporting

• does not require batch‑level transparency

• does not require disclosure to patients

This is why remediation is so common in limited‑license states — it protects operator inventory.

5. Georgia has NO public COA database

This is the structural flaw that enables undisclosed remediation:

• no public COA portal

• no batch history

• no pre‑remediation COAs

• no remediation logs

• no transparency requirements

Patients cannot verify:

• what failed

• why it failed

• what was done to fix it

• what chemicals were used

• whether the terpene profile is natural

• whether potency was corrected

• whether the product was irradiated

Georgia’s system is designed so the operator controls all information.

6. What Georgia does require (the bare minimum)

Georgia only requires:

• the final COA

• the product to pass the final test

• the operator to keep records internally

• the lab to maintain chain‑of‑custody

• the operator to comply with audits

There is no requirement to show the state:

• failed tests

• remediation logs

• pre‑remediation COAs

• chemical treatment records

• terpene correction records

And there is no requirement to show patients anything.

What is the purpose of terpene stripping and re‑infusion?

Terpene stripping and re‑infusion is the quiet, hidden practice that turns failed cannabis into “sellable” cannabis without ever telling the patient what happened.

Remediation destroys natural terpenes. Stripping removes whatever remnants survive. Re‑infusion adds manufactured terpenes back into the flower to restore smell, flavor, and “strain identity.”

The purpose is simple:

To cosmetically restore remediated cannabis so patients never know the batch failed.

Summary

Georgia allows remediation. Georgia does not disclose remediation. Georgia does not publish failed tests. Georgia does not require destruction of failed batches. Georgia does not require operators to tell patients anything. Georgia only shows the final, post‑remediation COA.

Remediated cannabis is not the same plant anymore — and Georgia hides the entire process.

And because Georgia uses only one testing lab, the entire system depends on secrecy. A second independent lab is the only structural fix.